| The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ... Journal of virology 85 (10), 4828-4840, 2011 | 591 | 2011 |
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors M Bonsignori, KK Hwang, X Chen, CY Tsao, L Morris, E Gray, DJ Marshall, ... Journal of virology 85 (19), 9998-10009, 2011 | 501 | 2011 |
| Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C JM Binley, EA Lybarger, ET Crooks, MS Seaman, E Gray, KL Davis, ... Journal of virology 82 (23), 11651-11668, 2008 | 418 | 2008 |
| Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection ES Gray, PL Moore, IA Choge, JM Decker, F Bibollet-Ruche, H Li, ... Journal of virology 81 (12), 6187-6196, 2007 | 416 | 2007 |
| Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape PL Moore, ES Gray, CK Wibmer, JN Bhiman, M Nonyane, DJ Sheward, ... Nature medicine 18 (11), 1688-1692, 2012 | 374 | 2012 |
| Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma ES Gray, H Rizos, AL Reid, SC Boyd, MR Pereira, J Lo, V Tembe, ... Oncotarget 6 (39), 42008, 2015 | 344 | 2015 |
| Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ... PLoS pathogens 5 (9), e1000598, 2009 | 273 | 2009 |
| Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients P Zaenker, ES Gray, MR Ziman Autoimmunity reviews 15 (5), 477-483, 2016 | 242 | 2016 |
| Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals GD Tomaras, JM Binley, ES Gray, ET Crooks, K Osawa, PL Moore, ... Journal of virology 85 (21), 11502-11519, 2011 | 239 | 2011 |
| Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes CK Wibmer, JN Bhiman, ES Gray, N Tumba, SS Abdool Karim, ... PLoS pathogens 9 (10), e1003738, 2013 | 224 | 2013 |
| Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors ES Gray, N Taylor, D Wycuff, PL Moore, GD Tomaras, CK Wibmer, ... Journal of virology 83 (17), 8925-8937, 2009 | 211 | 2009 |
| The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection PL Moore, ES Gray, IA Choge, N Ranchobe, K Mlisana, SS Abdool Karim, ... Journal of virology 82 (4), 1860-1869, 2008 | 202 | 2008 |
| Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop PL Moore, ES Gray, D Sheward, M Madiga, N Ranchobe, Z Lai, ... Journal of virology 85 (7), 3128-3141, 2011 | 200 | 2011 |
| Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting L Morris, X Chen, M Alam, G Tomaras, R Zhang, DJ Marshall, B Chen, ... PloS one 6 (9), e23532, 2011 | 180 | 2011 |
| The development of CD4 binding site antibodies during HIV-1 infection RM Lynch, L Tran, MK Louder, SD Schmidt, M Cohen, ... Journal of virology 86 (14), 7588-7595, 2012 | 155 | 2012 |
| Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? DB Asante, L Calapre, M Ziman, TM Meniawy, ES Gray Cancer letters 468, 59-71, 2020 | 146 | 2020 |
| Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region ES Gray, MC Madiga, PL Moore, K Mlisana, SS Abdool Karim, JM Binley, ... Journal of virology 83 (21), 11265-11274, 2009 | 133 | 2009 |
| High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination KL Davis, ES Gray, PL Moore, JM Decker, A Salomon, DC Montefiori, ... Virology 387 (2), 414-426, 2009 | 129 | 2009 |
| Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma L Calapre, L Warburton, M Millward, M Ziman, ES Gray Cancer letters 404, 62-69, 2017 | 126 | 2017 |
| Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin KB Alexandre, ES Gray, BE Lambson, PL Moore, IA Choge, K Mlisana, ... Virology 402 (1), 187-196, 2010 | 126 | 2010 |
Lynn MorrisNational Institute for Communicable DiseasesVerified email at nicd.ac.za
